tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
BridgeBio price target raised to $68 from $63 at Piper Sandler
PremiumThe FlyBridgeBio price target raised to $68 from $63 at Piper Sandler
7d ago
Cautious Hold Rating for BridgeBio Pharma Amid Attruby Sales Focus and BBP-418 Regulatory Prospects
Premium
Ratings
Cautious Hold Rating for BridgeBio Pharma Amid Attruby Sales Focus and BBP-418 Regulatory Prospects
7d ago
BridgeBio Pharma’s Promising Prospects: Buy Rating Driven by BBP-418’s Potential in Rare Neuromuscular Disorder
Premium
Ratings
BridgeBio Pharma’s Promising Prospects: Buy Rating Driven by BBP-418’s Potential in Rare Neuromuscular Disorder
7d ago
Microsoft upgraded, Instacart initiated: Wall Street’s top analyst calls
PremiumThe FlyMicrosoft upgraded, Instacart initiated: Wall Street’s top analyst calls
12d ago
Oppenheimer upgrades BridgeBio on execution, data catalysts
Premium
The Fly
Oppenheimer upgrades BridgeBio on execution, data catalysts
12d ago
BridgeBio upgraded to Outperform from Perform at Oppenheimer
Premium
The Fly
BridgeBio upgraded to Outperform from Perform at Oppenheimer
12d ago
3 Best Stocks to Buy Now, 6/26/2025, According to Top Analysts
PremiumMarket News3 Best Stocks to Buy Now, 6/26/2025, According to Top Analysts
25d ago
BridgeBio to host limb-girdle muscular dystrophy type 2I/R9 webinar
Premium
The Fly
BridgeBio to host limb-girdle muscular dystrophy type 2I/R9 webinar
25d ago
BridgeBio price target raised to $54 from $50 at BofA
Premium
The Fly
BridgeBio price target raised to $54 from $50 at BofA
26d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100